Is there a PSA cut-off value indicating incidental prostate cancer in patients undergoing surgery for benign prostatic hyperplasia?

Tonyali S., Ceylan C., Aglamis E., Dogan S., Tastemur S., Karaaslan M.

ARCHIVIO ITALIANO DI UROLOGIA E ANDROLOGIA, cilt.93, sa.1, ss.31-34, 2021 (ESCI) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 93 Sayı: 1
  • Basım Tarihi: 2021
  • Doi Numarası: 10.4081/aiua.2021.1.31
  • Dergi Adı: ARCHIVIO ITALIANO DI UROLOGIA E ANDROLOGIA
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, Academic Search Premier, EMBASE, MEDLINE, Directory of Open Access Journals
  • Sayfa Sayıları: ss.31-34
  • İstanbul Üniversitesi Adresli: Evet

Özet

Aim: To investigate incidental prostate cancer (IPCa) rate and to determine prostate specific antigen (PSA) cut-off value indicating PCa in patients who underwent surgery by being diagnosed with benign prostatic hyperplasia (BPH) clinically or by standard prostate biopsy.